Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Liu JC
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=4.711
------>paper_class3=2
------>paper_class2=1
------>vol=
------>confirm_bywho=None
------>insert_bywho=hippy
------>Jurnal_Rank=10.2
------>authors4_c=
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=
------>medlineContent=
------>unit=E0100
------>insert_date=20091015
------>iam=2
------>update_date=None
------>author=???
------>change_event=1
------>ISSN=
------>authors_c=
------>score=500
------>journal_name=Mol Pharmacol
------>paper_name=Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor.
------>confirm_date=None
------>tch_id=093148
------>pmid=19755521
------>page1=
------>fullAbstract=Urotensin II (U-II) is implicated in cardiomyocyte hypertrophy, which results in cardiac remodeling. We recently demonstrated that both reactive oxygen species (ROS) generation and epidermal growth factor receptor (EGFR) transactivation play critical roles in U-II signal transduction. However, the detailed intracellular mechanism(s) underlying cardiac hypertrophy and remodeling remain unclear. In this study, we used rat cardiomyocytes treated with U-II to investigate the association between ROS generation and EGFR transactivation. U-II treatment was found to stimulate cardiomyocyte hypertrophy through phosphorylation of EGFR and ROS generation. Apocynin, an NAD(P)H oxidase inhibitor, and the ROS scavenger N-acetyl cysteine (NAC), both inhibited EGFR transactivation induced by U-II. In contrast, AG-1478 (an EGFR inhibitor) failed to inhibit intracellular ROS generation induced by U-II. Src homology 2-containing tyrosine phosphatase (SHP-2), but not protein tyrosine phosphatase 1B (PTP 1B), was shown to be associated with EGFR during U-II treatment by EGFR co-immunoprecipitation. ROS have been reported to transiently oxidize the catalytic cysteine of phosphotyrosine phosphatases, subsequently inhibiting their activity. We examined the effect of U-II on SHP-2 and PTP 1B in cardiomyocytes using a modified malachite green phosphatase assay. SHP-2, but not PTP 1B, was transiently oxidized during U-II treatment, which could be repressed by NAC treatment. In SHP-2 knockdown cells, U-II-induced phosphorylation of EGFR and myocyte hypertrophy were dramatically elevated, and these effects were not influenced by NAC. Our data suggest that U-II-mediated ROS generation can transiently inhibit SHP-2 activity, thereby facilitating EGFR transactivation and hypertrophic signal transduction in rat cardiomyocytes.
------>tmu_sno=None
------>sno=22710
------>authors2=Chen CH
------>authors3=Chen JJ
------>authors4=Cheng TH
------>authors5=
------>authors6=
------>authors6_c=
------>authors=Liu JC
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=
------>publish_area=0
------>updateTitle=Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2009
------>submit_flag=None
------>publish_month=9
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z